KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Petmed Express (PETS) over the last 15 years, with Q4 2025 value amounting to $20.3 million.

  • Petmed Express' Accounts Payables rose 8547.28% to $20.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $20.3 million, marking a year-over-year increase of 8547.28%. This contributed to the annual value of $23.6 million for FY2025, which is 3635.48% down from last year.
  • Petmed Express' Accounts Payables amounted to $20.3 million in Q4 2025, which was up 8547.28% from $19.1 million recorded in Q3 2025.
  • In the past 5 years, Petmed Express' Accounts Payables ranged from a high of $40.0 million in Q2 2023 and a low of $10.9 million during Q4 2024
  • For the 5-year period, Petmed Express' Accounts Payables averaged around $24.6 million, with its median value being $24.1 million (2022).
  • In the last 5 years, Petmed Express' Accounts Payables soared by 13508.31% in 2023 and then plummeted by 7182.83% in 2024.
  • Quarter analysis of 5 years shows Petmed Express' Accounts Payables stood at $21.9 million in 2021, then increased by 10.86% to $24.3 million in 2022, then skyrocketed by 59.77% to $38.9 million in 2023, then tumbled by 71.83% to $10.9 million in 2024, then soared by 85.47% to $20.3 million in 2025.
  • Its Accounts Payables stands at $20.3 million for Q4 2025, versus $19.1 million for Q3 2025 and $20.0 million for Q2 2025.